Bolt Biotherapeutics, Inc. (BOLT) NASDAQ

4.78

-0.2861(-5.64%)

Updated at August 19 04:00PM

Currency In USD

Valuation

Market Cap408.57M
Enterprise Value426.57M
P/E Ratio-2.9
PEG Ratio4.81
Price/Sales Ratio2.52
Price/Book Ratio3.92
Enterprise/Revenue7.01
Enterprise/EBITDA-0.41

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-17.41
Operating Margin-18.71

Management Effectiveness

Return On Assets-0.74
Return On Equity-0.97

Income Statement

Revenue7.69M
Revenue/Share0.09
Gross Profit5.51M
EBITDA-66.46M
Net Income-63.12M
Diluted EPS-1.65

Balance Sheet

Total Cash38.84M
Total Cash/Share1.01
Total Debt24.71M
Total Debt/Equity0.53
Current Ratio3.13
Book Value Per Share1.22

Price History

52-Week Change-65.38
52-Week High14.36
52-Week Low4.76
Moving Average 50 Days5.83
Moving Average 200 Days8.46

Statistics

Average Volume29,634
Shares Outstanding1.92M
% Held by Institutions2.39

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateJune 09, 2025